| Dec'19 | Dec'18 | Dec'17 | Dec'16 | |||
|---|---|---|---|---|---|---|
License revenue | ||||||
15,678 | - | - | - | |||
Operating expenses: | ||||||
Research and development | ||||||
83,792 | 56,673 | 37,174 | 14,464 | |||
General and administrative | ||||||
20,418 | 15,432 | 8,130 | 5,153 | |||
Total operating expenses | ||||||
104,210 | 72,105 | 45,304 | 19,617 | |||
Loss from operations | ||||||
-88,532 | -72,105 | -45,304 | -19,617 | |||
Other income (expenses): | ||||||
Remeasurement loss on contingent repayment obligation | ||||||
2,554 | 331 | - | - | |||
Interest and other income, net | ||||||
3,465 | 2,066 | 406 | 78 | |||
Net loss | ||||||
-87,621 | -70,370 | -44,898 | -19,539 | |||
Unrealized gains (losses) on available-for-sale securities | ||||||
174 | -38 | -44 | - | |||
Comprehensive loss | ||||||
-87,447 | -70,408 | -44,942 | -19,539 | |||
Net loss per share, basic and diluted | ||||||
-2.40 | -3.75 | -6.94 | -3.15 | |||
Shares used in computing net loss per share, basic and diluted | ||||||
36,434 | 18,768 | 6,468 | 6,197 | |||